Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

CryoPort (NASDAQ:CYRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that CryoPort will report an earnings per share (EPS) of $-0.22.

Benzinga

Check Out What Whales Are Doing With SBUX

Someone with a lot of money to spend has taken a bullish stance on Starbucks (NASDAQ:SBUX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Texas Roadhouse's Earnings Outlook

Texas Roadhouse (NASDAQ:TXRH) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Texas Roadhouse will report an earnings per share (EPS) of $0.91.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

EyePoint, Expands Pact With Betta Pharma For EYP-1901 In China, Posts Deeper Q1 Loss

EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) executed a license agreement with Betta Pharmaceuticals Co Ltd to develop and commercialize EYP-1901 in Mainland China, Hong Kong, Macau, and Taiwan. This agreement expands the collaboration between EyePoint and Equinox Sciences, LLC, a Betta Pharmaceuticals affiliate established in February 2020. EyePoint will retain global ophthalmic rights for EYP-1901 in the…

Benzinga

Analyzing Booking Holdings's Short Interest

Booking Holdings's (NASDAQ:BKNG) short percent of float has risen 15.0% since its last report. The company recently reported that it has 751.20 thousand shares sold short, which is 1.84% of all regular shares that are available for trading.

Benzinga

Analyst Ratings for Sage Therapeutics

Over the past 3 months, 7 analysts have published their opinion on Sage Therapeutics (NASDAQ:SAGE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Looking Into Lam Research's Recent Short Interest

Lam Research's (NASDAQ:LRCX) short percent of float has fallen 20.47% since its last report. The company recently reported that it has 1.40 million shares sold short, which is 1.01% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Here's Why Tesla Could Make A Big Move After Fed Decision

Tesla, Inc (NASDAQ: TSLA) was trading down about 2% on Wednesday, breaking bearishly from an inside bar pattern the stock had been developing. An inside bar pattern indicates a period of consolidation and is usually followed by a continuation move in the direction of the current trend.

Benzinga

Here's How Much $100 Invested In Align Tech 10 Years Ago Would Be Worth Today

Align Tech (NASDAQ:ALGN) has outperformed the market over the past 10 years by 13.17% on an annualized basis producing an average annual return of 24.91%. Currently, Align Tech has a market capitalization of $22.92 billion.

Benzinga

Rivian Automotive Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Rivian Automotive. Looking at options history for Rivian Automotive (NASDAQ:RIVN) we detected 15 strange trades.

Benzinga

Why Skyworks Solutions Shares Are Falling Today

Skyworks Solutions Inc (NASDAQ: SWKS) shares are trading lower Wednesday after the company reported financial results and issued guidance below analyst estimates.

Benzinga

TransMedics Stock Skyrockets On Increased 2022 Guidance

TransMedics Group Inc (NASDAQ:TMDX) shares got a massive boost after better than expected Q1 earnings and 2022 guidance. The company posted an EPS loss of $(0.38) in line with expectations and higher than $(0.29) a year ago despite more than doubling its sales from Q1 FY21. Net revenue of $15.9 million increased 125%…

Benzinga

A Preview Of Allscripts Healthcare's Earnings

Allscripts Healthcare (NASDAQ:MDRX) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Allscripts Healthcare will report an earnings per share (EPS) of $0.21.

Benzinga

Earnings Outlook For Luminar Technologies

Luminar Technologies (NASDAQ:LAZR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Luminar Technologies will report an earnings per share (EPS) of $-0.13.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

$1000 Invested In Analog Devices 10 Years Ago Would Be Worth This Much

Analog Devices (NASDAQ:ADI) has outperformed the market over the past 10 years by 3.61% on an annualized basis producing an average annual return of 15.38%. Currently, Analog Devices has a market capitalization of $81.95 billion.

Benzinga

MercadoLibre Earnings Preview

MercadoLibre (NASDAQ:MELI) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that MercadoLibre will report an earnings per share (EPS) of $1.35.

Benzinga

What Are Whales Doing With MicroStrategy

Someone with a lot of money to spend has taken a bearish stance on MicroStrategy (NASDAQ:MSTR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Yankees' Aaron Judge Hits A Home Run That Creates A Lifelong Friendship: How It Happened

There might be crying in baseball after all, thanks to a wonderful moment between fans caught on video.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Earnings Outlook For Lifetime Brands

Lifetime Brands (NASDAQ:LCUT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Lifetime Brands will report an earnings per share (EPS) of $0.07.

Benzinga

Earnings Outlook For Concert Pharmaceuticals

Concert Pharmaceuticals (NASDAQ:CNCE) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Concert Pharmaceuticals will report an earnings per share (EPS) of $-0.91.

Benzinga

Why Kezar Life Sciences Shares Are Getting Hammered

Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading lower by 38.23% at $7.61 after the company announced top-line results from its PRESIDIO Phase 2 clinical trial of Zetomipzomib.

Benzinga

Satellogic Shares Surge: Why SpaceX Is Fueling The Move

Satellogic Inc (NASDAQ: SATL) shares are trading higher Wednesday after the company announced it signed a new Multiple Launch Agreement (MLA) with SpaceX reserving launch capacity for its next 68 satellites.

Benzinga

Chemomab Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know

Chemomab Therapeutics (NASDAQ:CMMB) will host a conference call at 08:00 AM ET on May 12, 2022, to discuss Q1 2022 earnings results.

Benzinga

What's Going On With Oatly Shares Today?

Oatly Group AB - ADR (NASDAQ: OTLY) shares are trading flat at $3.46. The company reported better-than-expected first-quarter results Wednesday.

Benzinga

Sinclair Broadcast Clocks 15% Revenue Decline In Q1; Hopes On Political Advertising Cycle

Sinclair Broadcast Group, Inc (NASDAQ:SBGI) reported a first-quarter FY21 revenue decline of 14.8% year-on-year to $1.29 billion, missing the consensus of $1.53 billion. Total advertising revenues of $371 million were inline Y/Y. Distribution revenues of $873 million declined 21.3% Y/Y. Adjusted operating income increased 70% Y/Y to $114 million. EPS was $35.39 versus…

1 … 564 565 566 567

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.